| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |